Thierry Maudelondé

6.4k total citations
125 papers, 5.1k citations indexed

About

Thierry Maudelondé is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Thierry Maudelondé has authored 125 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 42 papers in Oncology and 40 papers in Genetics. Recurrent topics in Thierry Maudelondé's work include Estrogen and related hormone effects (33 papers), Protease and Inhibitor Mechanisms (15 papers) and Advanced Proteomics Techniques and Applications (15 papers). Thierry Maudelondé is often cited by papers focused on Estrogen and related hormone effects (33 papers), Protease and Inhibitor Mechanisms (15 papers) and Advanced Proteomics Techniques and Applications (15 papers). Thierry Maudelondé collaborates with scholars based in France, United States and Germany. Thierry Maudelondé's co-authors include Henri Rochefort, Jérôme Solassol, Catherine Alix‐Panabières, Alain Mangé, Klaus Pantel, Pascal Pujol, Laure Cayrefourcq, Jean‐Paul Brouillet, Caroline Desmetz and Pascal Roger and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Thierry Maudelondé

124 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Maudelondé France 41 2.2k 2.2k 1.9k 1.0k 551 125 5.1k
Ruth Holm Norway 45 2.8k 1.3× 2.8k 1.3× 1.3k 0.7× 403 0.4× 680 1.2× 187 6.1k
Dean B. Evans Switzerland 39 2.7k 1.2× 2.1k 1.0× 2.0k 1.1× 2.1k 2.1× 994 1.8× 107 5.6k
Maria Flavia Di Renzo Italy 40 1.9k 0.9× 4.0k 1.9× 995 0.5× 495 0.5× 959 1.7× 106 7.4k
Karin Milde‐Langosch Germany 42 1.9k 0.8× 3.2k 1.5× 1.8k 0.9× 448 0.4× 551 1.0× 130 5.6k
Charles Theillet France 55 4.0k 1.8× 5.3k 2.4× 2.6k 1.4× 1.9k 1.8× 774 1.4× 140 8.7k
Colette Charpin France 36 1.7k 0.8× 1.7k 0.8× 1.3k 0.7× 526 0.5× 358 0.6× 135 3.8k
Liana Adam United States 36 2.0k 0.9× 3.3k 1.5× 1.0k 0.5× 894 0.9× 551 1.0× 50 5.2k
Bjørn Risberg Norway 41 1.4k 0.6× 1.8k 0.8× 877 0.5× 263 0.3× 761 1.4× 131 4.6k
Kimberly R. Kalli United States 46 2.1k 0.9× 2.2k 1.0× 1.1k 0.6× 638 0.6× 387 0.7× 101 5.5k
S Hirohashi Japan 51 2.7k 1.2× 4.6k 2.1× 1.1k 0.6× 519 0.5× 1.2k 2.1× 133 8.7k

Countries citing papers authored by Thierry Maudelondé

Since Specialization
Citations

This map shows the geographic impact of Thierry Maudelondé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Maudelondé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Maudelondé more than expected).

Fields of papers citing papers by Thierry Maudelondé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Maudelondé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Maudelondé. The network helps show where Thierry Maudelondé may publish in the future.

Co-authorship network of co-authors of Thierry Maudelondé

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Maudelondé. A scholar is included among the top collaborators of Thierry Maudelondé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Maudelondé. Thierry Maudelondé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cayrefourcq, Laure, Thibault Mazard, Simon A. Joosse, et al.. (2015). Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells. Cancer Research. 75(5). 892–901. 284 indexed citations
2.
Mazel, Martine, William Jacot, Klaus Pantel, et al.. (2015). Frequent expression of PD‐L1 on circulating breast cancer cells. Molecular Oncology. 9(9). 1773–1782. 310 indexed citations
3.
Fehm, Tanja, Mattéa Orsini, Laure Cayrefourcq, et al.. (2013). Prognostic Relevance of Viable Circulating Tumor Cells Detected by EPISPOT in Metastatic Breast Cancer Patients. Clinical Chemistry. 60(1). 214–221. 93 indexed citations
4.
Mangé, Alain, Jérôme Lacombe, Caroline Mollévi, et al.. (2012). Serum Autoantibody Signature of Ductal Carcinoma In Situ Progression to Invasive Breast Cancer. Clinical Cancer Research. 18(7). 1992–2000. 31 indexed citations
5.
Boissière‐Michot, Florence, Evelyne Lopez‐Crapez, Alexandre Ho-Pun-Cheung, et al.. (2012). KRAS genotyping in rectal adenocarcinoma specimens with low tumor cellularity after neoadjuvant treatment. Modern Pathology. 25(5). 731–739. 28 indexed citations
6.
Mangé, Alain, Aurélie Goux, Stéphanie Badiou, et al.. (2012). HDL Proteome in Hemodialysis Patients: A Quantitative Nanoflow Liquid Chromatography-Tandem Mass Spectrometry Approach. PLoS ONE. 7(3). e34107–e34107. 58 indexed citations
7.
Desmetz, Caroline, Caroline Mollévi, Philippe Rochaix, et al.. (2009). Identification of a New Panel of Serum Autoantibodies Associated with the Presence of In situ Carcinoma of the Breast in Younger Women. Clinical Cancer Research. 15(14). 4733–4741. 87 indexed citations
8.
Delfour, Christophe, Pascal Roger, Caroline Bret, et al.. (2006). RCL2, a New Fixative, Preserves Morphology and Nucleic Acid Integrity in Paraffin-Embedded Breast Carcinoma and Microdissected Breast Tumor Cells. Journal of Molecular Diagnostics. 8(2). 157–169. 83 indexed citations
9.
Solassol, Jérôme, et al.. (2006). Clinical proteomics and mass spectrometry profiling for cancer detection. Expert Review of Proteomics. 3(3). 311–320. 39 indexed citations
10.
Maudelondé, Thierry & Lluís Fajas. (2005). PPAR γ ligands and the control of metabolism. 7(2). 127–132. 1 indexed citations
11.
Maudelondé, Thierry & Lluís Fajas. (2005). Contrôle du métabolisme par des ligands de PPARγ. 7(2). 127–132. 1 indexed citations
12.
Pujol, Pascal, Pascale This, Mehrdad Noruzinia, Dominique Stoppa‐Lyonnet, & Thierry Maudelondé. (2004). Les formes héréditaires de cancer du sein liées à BRCA1 et BRCA2 sont‐elles sensibles aux œstrogènes ?. Bulletin du Cancer. 91(7). 583–591. 4 indexed citations
13.
Rey, Jean‐Marc, et al.. (2003). 17β‐estradiol downregulates β3‐integrin expression in differentiating and mature human osteoclasts. Journal of Cellular Physiology. 198(2). 269–276. 20 indexed citations
14.
Brouillet, J.P., Dany Chalbos, Jean‐Marc Rey, et al.. (2001). Analysis of the potential contribution of estrogen receptor (ER) ? in ER cytosolic assay of breast cancer. International Journal of Cancer. 95(4). 205–208. 18 indexed citations
15.
Roger, Pascal, Thierry Maudelondé, C Pignodel, et al.. (2000). Dissociated overexpression of cathepsin Dand estrogen receptor alpha in preinvasive mammary tumors. Human Pathology. 31(5). 593–600. 35 indexed citations
16.
Pujol, Pascal, et al.. (2000). Neoadjuvant tamoxifen for operable breast cancer: a need for phase III studies?. PubMed. 24(5). 445–51. 3 indexed citations
17.
Brouillet, J.P., F. Spyratos, K. Hacène, et al.. (1993). Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: Relative prognostic value versus total cathepsin D. European Journal of Cancer. 29(9). 1248–1251. 28 indexed citations
18.
Escot, Chantal, Charles Theillet, Thierry Maudelondé, et al.. (1991). Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.. PubMed. 6(3). 431–7. 55 indexed citations
19.
Maudelondé, Thierry, J Domergue, Gilles Freiss, et al.. (1989). Tamoxifen treatment increases the concentration of 52K-cathepsin D and its precursor in breast cancer tissue. Cancer. 63(7). 1265–1270. 23 indexed citations
20.
Rochefort, Henri, Patrick Augereau, Pierre Briozzo, et al.. (1988). Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells. Biochimie. 70(7). 943–949. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Holm Breakdown of academic impact, for papers by Dean B. Evans Breakdown of academic impact, for papers by Maria Flavia Di Renzo Breakdown of academic impact, for papers by Karin Milde‐Langosch Breakdown of academic impact, for papers by Charles Theillet Breakdown of academic impact, for papers by Colette Charpin Breakdown of academic impact, for papers by Liana Adam Breakdown of academic impact, for papers by Bjørn Risberg Breakdown of academic impact, for papers by Kimberly R. Kalli Breakdown of academic impact, for papers by S Hirohashi
Rankless by CCL
2026